Cancer IQ Blog

Press Release: CancerIQ Wins Chicago Innovation Award

Posted by Alexa McCarthy on Oct 26, 2016 6:00:00 AM

Chicago, IL— CancerIQ, a cancer risk assessment software, was named a winner at the 15th annual Chicago Innovation Awards for its CancerIQ Risk software.

The Chicago Innovation Awards is the Chicago region’s foremost recognition of the most innovative new products or services brought to market or public service each year. The awards were presented at the Harris Theater on Oct. 25, recognizing the city’s top innovators out of record-breaking 643 nominations.

CancerIQ was founded in 2014 to develop a more efficient and scalable genetics process for patients in need. Today, the company is quickly growing and has served over 9,000 patients.

 “Our software gives thousands of more patients access to genetics care, allowing patients and providers the ability to predict and prevent hereditary cancer,” said Feyi Olopade, founder of CancerIQ. “Our commitment to patient-centered design in the rapidly growing genomics space symbolizes the spirit of the Chicago Innovation Awards.”

CancerIQ enables clinics of diverse sizes and populations to start, run and grow an impactful cancer risk program. CancerIQ uses predictive genomic analytics to identify patients at risk of breast, colon, and ovarian cancer; Then with robust clinical guidance and patient education and communication tools, CancerIQ gives providers the ability to navigate high-risk patients towards preventative care.

“Local innovators continue to illuminate the Chicago region as a growing hotbed of creative activity that cuts across all sectors and industries,” said Tom Kuczmarski, co-founder with Chicago journalist Dan Miller of the awards. “Every winner of the Chicago Innovation Awards demonstrates how a unique solution to an unmet need can bring transformative impact in the marketplace.”

“CancerIQ is very proud to receive this award,” said Olopade. “We love calling Chicago our home, as it has provided us with a rich innovation community to grow our product and company and ultimately achieve our goal of creating greater patient access to preventative cancer care.”

To learn more, visit

The complete list of this year’s Chicago Innovation Award winners can be found at


Topics: Press

A Little More About Us...

In 2014, an interdisciplinary team of experts in clinical cancer genetics convened to solve a growing problem – patient access. With such a small group of trained practitioners with genetics expertise, there was a need to make the process more efficient, team-based, and scalable.

We aim to bring predictive analytics to the world of cancer care, starting with simple tools to predict, pre-empt, and prevent adverse outcomes in cancer.

Subscribe to Email Updates